What are Stem Cell Transplantation Options for Patients Who Have Blood Cancers
- Blogs, Cancer, Health Tips, Treatment
- TeamMozocare
- September 23, 2022
The following information is a general summary and is not all-inclusive. Each patient has unique circumstances, so patients should discuss all appropriate therapies with their doctors.
Table of Contents
Acute lymphoblastic leukemia (ALL)
- The decision to perform a transplant for an adult who has ALL depends on the features of the leukemia, the patient’s general health and the patient’s age.
- An allogeneic stem cell transplant may be an option for patients with high-risk ALL whose disease is in remission for the first time or whose disease is in a partial remission (provided a suitable donor is available).
- The choice between allogeneic transplantation and continued chemotherapy is less clear for patients who have standard-risk ALL and whose disease is in first remission. These patients should discuss standard and/or reduced-intensity allogeneic stem cell transplantation with their doctors to determine if either of these types of transplants are recommended for them. A minimal amount of residual disease may influence the decision of whether or not to proceed to transplantation.
- Autologous stem cell transplantation outside of the clinical-trial setting is not recommended as treatment for ALL.
- Most children with ALL (about 75 to 80 percent) do not need stem cell transplantation. A child with refractory disease or relapsed ALL may be considered for allogeneic transplantation
Acute myeloid leukemia (AML)
- Favorable-risk AML: Stem cell transplantation is generally not recommended with first complete remission.
- Intermediate-risk AML: Patients with intermediate-risk AML should discuss standard and/or reduced-intensity stem cell allogeneic transplantation with their doctor to determine if one of these transplantations is recommended for them.
- High-risk AML: Allogeneic stem cell transplantation is generally recommended with first remission or in a partial remission for patients who are candidates for a transplant and have a suitable allogeneic donor. Reduced-intensity allogeneic stem cell transplantation may be recommended for older patients or patients who have certain comorbidities.
- Autologous stem cell transplantation outside of a clinical-trial setting is not commonly used to treat AML
Chronic lymphocytic leukemia (CLL)
- Allogeneic transplantation (usually reduced-intensity but sometimes standard) is under study in clinical trials as treatment for patients who have CLL that has certain high-risk features or disease that has relapsed after standard therapies
Chronic myeloid leukemia (CML)
- In cases of either advanced or refractory disease or intolerance of oral CML therapies, standard allogeneic stem cell transplantation (or reduced/intensity allogeneic stem cell transplantation) may be recommended for patients who have a suitable allogeneic donor available
Hodgkin lymphoma (HL)
- Autologous stem cell transplantation is used to treat HL patients whose disease relapses after initial therapy.
- Standard and reduced-intensity allogeneic stem cell transplantation are under study in clinical trials as treatment for HL patients who have a suitable allogeneic donor.
Non-Hodgkin lymphoma (NHL
- Autologous stem cell transplantation is generally used to treat patients who have relapsed or refractory disease; transplantation during first remission is done only in clinical trials, with the exception of some types of NHL, including certain cases of mantle cell lymphoma and T-cell lymphoma.
- Allogeneic transplantation is used to treat selected patients who have NHL.
- Patients should check with their doctors and find out if there are specific recommendations for their subtype of NHL.
Myelodysplastic syndromes (MDSs)
- A standard allogeneic stem cell transplant (or a reduced-intensity allogeneic stem cell transplant for older or other selected patients) may be recommended for people who have intermediate- or high-risk MDS and a suitable allogeneic donor available.
Myeloma
- Autologous stem cell transplantation is an important part of treatment for certain myeloma patients.
- Allogeneic stem cell transplantation is not commonly used for myeloma patients but it may be a treatment option for selected younger patients who have a suitable allogeneic donor available.
- Reduced-intensity allogeneic stem cell transplantation is used in some cases following autologous stem cell transplantation for patients who have a suitable allogeneic donor available.
Myeloproliferative neoplasms (MPNs)
- Myelofibrosis: A standard allogeneic stem cell transplant (or a reduced-intensity allogeneic stem cell transplant for older patients or patients who have certain comorbidities) may be recommended for patients who have a suitable allogeneic donor available.
- Polycythemia vera (PV) and essential thrombocythemia (ET): Allogeneic stem cell transplantation and reduced-intensity allogeneic stem cell transplantation are occasionally used to treat these diseases.
Have a question ?
If you have any questions about Blood and Marrow Stem Cell Transplantation
Contact for Second Opinion or Free Counselling
Call +1 (302) 451 9218
Related Articles
Cervical Cancer Treatment Cost In India
Laparoscopy Surgery Cost In India
Spine Decompression Surgery Cost In India
Cardiomyopathy Treatment Cost In India
Cost Of Dental Implants In India
Cost of Tummy Tuck Treatment In India
Chemotherapy Cost In India
Kidney Transplant Cost In India
Liposuction Treatment Cost In India
Cost of Heart Transplant In India | Cardiology | Mozocare
Tags
bariatric surgery
Best Hospitals
Best Oncologist in India
Best Orthopedic Doctor
cancer
cancer treatment
Cardiomyopathy
chemotherapy
Colon Cancer
Coronavirus
coronavirus in delhi
coronavirus in india
coronavirus symptoms
Coronavirusupdate
Cost Guide
Cost of Kidney Transplant
covid-19
COVID-19 PANDEMIC
covid-19 resource
Deadly And Mysterious Coronavirus Outbreak
Dr. S Dinesh Nayak
hair
hair transplant
hair transplant treatment
hair transplant treatment cost
hair transplant treatment cost in india
healthcare updates
Hospital Ranking
hospitals for Knee Replacement Surgery
Kidney Transplant
Kidney Transplant Cost
Liver
Liver cancer
liver transplant
Liver Transplant cost
Medical Devices
neuro surgeon
Oncologist
Podcast
top 10
Top 10 neurologists in India
Treatment Innovation
Tummy Tuck
What does a neurologist do?
What is a neurologist?
This post first appeared on Top 10 Gastroenterologist In India | Mozocare India, please read the originial post: here
